Top | S-Quatre Corporation

エディタV2

Power of child’s stem cells to Fight incurable diseases

お知らせ：表示

2025/10/08：Collaborative Research Results with S-Quatre to be Presented by Nagoya University at the 75th Congress of Neurological Surgeons in Los Angels (CNS 2025): The Department of Neurosurgery in Nagoya University will present the results of its collaborative research with S-Quatre at the 75th Annual Meeting of the Congress of Neurological Surgeons (CNS 2025), one of the world’s largest neurosurgical conferences, to be held from October 11, 2025. The presentation was selected for oral presentation by the conference committee from among numerous submissions.

This research aims to develop a novel therapeutic approach for peripheral nerve injury using our stem cells (SQ-SHED), and part of the study’s findings was published in a scientific paper in August 2025^*1). This congress, organized by the Congress of Neurological Surgeons, is one of the world’s leading international academic meetings, bringing together neurosurgical experts to share and explore the latest surgical techniques and therapeutic innovations. This presentation represents an important recognition of the collaborative research efforts between Nagoya University and S-Quatre on an international stage.

Presentation Title
Stem Cells From Human Exfoliated Deciduous Teeth Improves Motor Function After Sciatic Nerve Injury Through Suppression Of Inflammation

Website : 75th Congress of Neurological Surgeons Annual Meeting
https://www.cns.org/annualmeeting

Related release
1) Publication of Research Paper on the Application of SHED in the Treatment of Peripheral Nerve Injuries, August 14, 2025

エディタV2

Aiming for the World's First Cell Therapy Using SHED

Research of regenerative medicine using various types of cells has been actively performed around the world. We focused on SHED “stem cells from a child’s tooth” and are strenuously conducting the research and development to realize a new cell therapeutics for various intractable diseases.

エディタV2

S-Quatre^® – Stable Manufacturing and Supply System of Cell Banks for Cell Therapeutics

Practical application of cell therapeutics needs to stably procure donor tissue sources, manufacture cell banks, and supply them. We established a stable manufacturing and supply system of SHED banks named S-Quatre^® by our own technology and network, composing a platform of the development of our cell therapeutics.